ClinicalTrials.Veeva

Menu

Quality Control and Evaluation in Standard COPD Management

T

Tongji Hospital

Status

Completed

Conditions

COPD

Treatments

Other: GOLD 2017

Study type

Observational

Funder types

Other

Identifiers

NCT03314077
TongjiHospitalResp.

Details and patient eligibility

About

There is lack of quality control and evaluation indexes for standard COPD management in hospitals in China, leading to nonstandard in COPD management and discrepancy in therapeutic efficiency. This study focuses on establishing quality control and evaluation indexes for standard COPD management in hospitals in China, and evaluating the therapeutic efficiency after standard COPD management. This part is a prospective cohort which lasts 2 years. After standard COPD management according to GOLD 2017 by doctors in hospitals in China, patients will be followed up for their outcome after 1 year. Several indexes will be selected to evaluate the quality control of standard COPD management and its efficiency. The controls are from hospital-based subjects with a retrospective cohort study.

Enrollment

210 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1.Clinical manifestation of COPD; post bronchodilator FEV1/FVC<0.70

Exclusion criteria

    1. lung cancer. 2. Any history of psychiatric disorders. 3.HIV positive. 4.Breastfeeding, pregnancy or planning to be pregnant. 5.Estimated lifetime less than 1 years due to underlying diseases.

Trial design

210 participants in 2 patient groups

Standard managed subjects
Description:
COPD patients accepted standard COPD management.
Treatment:
Other: GOLD 2017
Controls
Description:
COPD patients didn't accepted standard COPD management or quality control, who are from hospital subjects with a retrospective cohort study.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems